Skip to main navigation
Skip to main content
Skip to Footer
Global
Sandoz Site Directory
Our Work
What We Do
Disease Areas
Prescription Medicines
Over-The-Counter Medicines
Partnerships and Collaborations
Biopharmaceuticals
About Us
Who We Are
Corporate Responsibility
Doing Business Responsibly
Investor Information
Contact Us
Diversity & Inclusion
News
All News
Media Releases
Publications
Media Library
Stay Up-To-Date
Media Contacts
Careers
Job Search
Working at Sandoz
Search
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Filter By
2022
June
Media Release
/
Jun 17, 2022
Sandoz Application for proposed biosimilar adalimumab’s high concentration formulation accepted by EMA
Read More
Media Release
/
Jun 10, 2022
HEXAL launches Dimethyl fumarate HEXAL® a generic drug for Tecfidera®, in Germany, offering an economically efficient treatment option for the care of adult patients with multiple sclerosis*
Read More
Featured News
/
Jun 07, 2022
Living with Multiple Sclerosis (MS) – A disease with 1000 faces
Read More
May
Media Release
/
May 31, 2022
Sandoz announces new global ‘Act4Biosimilars’ initiative, to improve patient access and increase adoption by at least 30% in 30+ countries by 2030
Read More
Media Release
/
May 27, 2022
Sandoz appoints new Board representative to global AMR Industry Alliance
Read More
Media Release
/
May 12, 2022
Sandoz launches first generic pirfenidone in US for patients with idiopathic pulmonary fibrosis, growing its respiratory portfolio
Read More
April
Media Release
/
Apr 26, 2022
Novartis delivers solid sales and profit growth. Strong performance of in-market brands supports confidence in mid-term growth outlook
Read More
Media Release
/
Apr 14, 2022
Sandoz launches generic brimonidine tartrate/timolol maleate eyedrop in US for patients with ocular hypertension, expanding leading ophthalmic portfolio
Read More
Media Release
/
Apr 06, 2022
Sandoz extends collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)
Read More
March
Media Release
/
Mar 14, 2022
Sandoz targets growth opportunities in respiratory and complex generics through acquisition of respiratory device company Coalesce
Read More
Search Results Navigation
Current page
1
of 5
Page
2
of 5
Page
3
of 5
Page
4
of 5
Page
5
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Whatsapp
Jump to Comments
Print
Save
You are here
Home
›
News
›